| Adverse Event | US Count of AE reports post Vaccine | US Rate of reported AE<br/>(count/Month) | US Rate of reported AE<br/>(count/billion doses) | US Rate of reported AE<br/>(count/billion people vaccinated) |
| --- | --: | --: | --: | --: |
| Abnormal uterine bleeding (menstrual irregularity) | 6352<br/>54 | 353<br/>0.192 | 10700<br/>16.4 | 24400<br/>139 |
| Miscarriage | 1232<br/>259 | 68.4<br/>0.922 | 2070<br/>78.5 | 4740<br/>668 |
| Fetal chromosomal abnormalities | 7<br/>0 | 0.389<br/>0.00 | 11.7<br/>0.00 | 26.9<br/>0.00 |
| Fetal malformation | 2<br/>1 | 0.111<br/>0.00356 | 3.35<br/>0.303 | 7.69<br/>2.58 |
| Fetal cystic hygroma | 5<br/>0 | 0.278<br/>0.00 | 8.39<br/>0.00 | 19.2<br/>0.00 |
| Fetal cardiac disorders | 10<br/>2 | 0.556<br/>0.00712 | 16.8<br/>0.606 | 38.5<br/>5.15 |
| Fetal arrhythmia | 3<br/>0 | 0.167<br/>0.00 | 5.03<br/>0.00 | 11.5<br/>0.00 |
| Fetal cardiac arrest | 3<br/>0 | 0.167<br/>0.00 | 5.03<br/>0.00 | 11.5<br/>0.00 |
| Fetal vascular mal-perfusion | 5<br/>0 | 0.278<br/>0.00 | 8.39<br/>0.00 | 19.2<br/>0.00 |
| Fetal growth abnormalities | 59<br/>20 | 3.28<br/>0.0712 | 99.0<br/>6.06 | 227<br/>51.5 |
| Fetal abnormal surveillance | 125<br/>36 | 6.94<br/>0.128 | 210<br/>10.9 | 481<br/>92.8 |
| Fetal placental thrombosis | 5<br/>0 | 0.278<br/>0.00 | 8.39<br/>0.00 | 19.2<br/>0.00 |
| Fetal death (stillbirth) | 168<br/>42 | 9.33<br/>0.149 | 282<br/>12.7 | 646<br/>108 |
